294 related articles for article (PubMed ID: 32580186)
1. Diagnosis, Background, and Treatment of Hypothalamic Damage in Craniopharyngioma.
Erfurth EM
Neuroendocrinology; 2020; 110(9-10):767-779. PubMed ID: 32580186
[TBL] [Abstract][Full Text] [Related]
2. Management of Hypothalamic Obesity.
Müller HL
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):533-552. PubMed ID: 32741487
[TBL] [Abstract][Full Text] [Related]
3. Craniopharyngioma treatment: an updated summary of important clinicopathological concepts.
Prieto R; Rosdolsky M; Hofecker V; Barrios L; Pascual JM
Expert Rev Endocrinol Metab; 2020 Jul; 15(4):261-282. PubMed ID: 32615875
[TBL] [Abstract][Full Text] [Related]
4. Craniopharyngioma-An update on metabolic and cognitive complications and new therapy.
Erfurth EM
J Intern Med; 2023 Sep; 294(3):269-280. PubMed ID: 37424210
[TBL] [Abstract][Full Text] [Related]
5. Childhood craniopharyngioma - changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007.
Hoffmann A; Warmth-Metz M; Gebhardt U; Pietsch T; Pohl F; Kortmann RD; Calaminus G; Müller HL
Klin Padiatr; 2014 May; 226(3):161-8. PubMed ID: 24819386
[TBL] [Abstract][Full Text] [Related]
6. Childhood-onset craniopharyngioma: latest insights into pathology, diagnostics, treatment, and follow-up.
Bogusz A; Müller HL
Expert Rev Neurother; 2018 Oct; 18(10):793-806. PubMed ID: 30257123
[TBL] [Abstract][Full Text] [Related]
7. Advances in the management of craniopharyngioma in children and adults.
Jensterle M; Jazbinsek S; Bosnjak R; Popovic M; Zaletel LZ; Vesnaver TV; Kotnik BF; Kotnik P
Radiol Oncol; 2019 Oct; 53(4):388-396. PubMed ID: 31652121
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging-graded hypothalamic compression in surgically treated adult craniopharyngiomas determining postoperative obesity.
Van Gompel JJ; Nippoldt TB; Higgins DM; Meyer FB
Neurosurg Focus; 2010 Apr; 28(4):E3. PubMed ID: 20367360
[TBL] [Abstract][Full Text] [Related]
9. Preservation of Hypothalamic Function with Endoscopic Endonasal Resection of Hypothalamus-Invaded Craniopharyngiomas.
Yang L; Xie SH; Fang C; Zeng EM; Tang B; Hong T
World Neurosurg; 2019 Dec; 132():e841-e851. PubMed ID: 31398519
[TBL] [Abstract][Full Text] [Related]
10. Craniopharyngioma therapy: long-term effects on hypothalamic function.
Ullrich NJ; Scott RM; Pomeroy SL
Neurologist; 2005 Jan; 11(1):55-60. PubMed ID: 15631644
[TBL] [Abstract][Full Text] [Related]
11. Surgical Outcomes of Endoscopic Endonasal Skull Base Surgery of Craniopharyngiomas Evaluated According to the Degree of Hypothalamic Extension.
Yano S; Hide T; Shinojima N
World Neurosurg; 2017 Apr; 100():288-296. PubMed ID: 28089805
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review.
van Iersel L; Brokke KE; Adan RAH; Bulthuis LCM; van den Akker ELT; van Santen HM
Endocr Rev; 2019 Feb; 40(1):193-235. PubMed ID: 30247642
[TBL] [Abstract][Full Text] [Related]
13. Interventions for the Treatment of Craniopharyngioma-Related Hypothalamic Obesity: A Systematic Review.
Ni W; Shi X
World Neurosurg; 2018 Oct; 118():e59-e71. PubMed ID: 29945001
[TBL] [Abstract][Full Text] [Related]
14. Approach to the Patient With Hypothalamic Obesity.
Shoemaker AH; Tamaroff J
J Clin Endocrinol Metab; 2023 Apr; 108(5):1236-1242. PubMed ID: 36413492
[TBL] [Abstract][Full Text] [Related]
15. Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity.
Roth CL; Eslamy H; Werny D; Elfers C; Shaffer ML; Pihoker C; Ojemann J; Dobyns WB
Obesity (Silver Spring); 2015 Jun; 23(6):1226-33. PubMed ID: 25884561
[TBL] [Abstract][Full Text] [Related]
16. Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging.
de Vile CJ; Grant DB; Hayward RD; Kendall BE; Neville BG; Stanhope R
J Clin Endocrinol Metab; 1996 Jul; 81(7):2734-7. PubMed ID: 8675604
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic obesity in a patient with craniopharyngioma: dysregulation of neurohormonal control of energy balance.
Maniatis AK; Simmons JH; Zeitler PS
Curr Opin Pediatr; 2005 Apr; 17(2):275-9. PubMed ID: 15800425
[No Abstract] [Full Text] [Related]
18. Papillary Craniopharyngioma: A Type of Tumor Primarily Impairing the Hypothalamus - A Comprehensive Anatomo-Clinical Characterization of 350 Well-Described Cases.
Prieto R; Barrios L; Pascual JM
Neuroendocrinology; 2022; 112(10):941-965. PubMed ID: 35108706
[TBL] [Abstract][Full Text] [Related]
19. Acquired hypothalamic obesity: A clinical overview and update.
Roth CL; McCormack SE
Diabetes Obes Metab; 2024 Apr; 26 Suppl 2():34-45. PubMed ID: 38450938
[TBL] [Abstract][Full Text] [Related]
20. Risk-adapted, long-term management in childhood-onset craniopharyngioma.
Müller HL
Pituitary; 2017 Apr; 20(2):267-281. PubMed ID: 27604996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
